Table 3.
Responses Reflect Participant Responses of Strongly Agreeing or Agreeing That They Would Be Less Likely to Receive Breast Implants after They Were Provided with a Given Piece of Information from the FDA Boxed Warning on Breast Implants during the Survey
| FDA Boxed Warning | Respondent Characteristic | OR (95% CI) | P |
|---|---|---|---|
| Not considered lifetime devices | Hispanic ethnicity | 2.35 (1.33–4.39) | 0.005 |
| Annual household income ≥$50,000 | 0.64 (0.42–0.96) | 0.033 | |
| Risk of BIA-ALCL | Hispanic ethnicity | 2.04 (1.12–3.94) | 0.026 |
| Risk of systemic symptoms | Other insurance type* | 4.48 (1.39–16.3) | 0.016 |
| Annual household income ≥$50,000 | 0.52 (0.34–0.79) | 0.002 | |
| Recommendation of initial screening for rupture | Hispanic ethnicity | 1.78 (1.05–3.09) | 0.037 |
| ADH | 2.44 (1.47–4.08) | <0.001 | |
| Private health insurance | 0.56 (0.37–0.84) | 0.005 | |
| Recommendation of continued screening for rupture | Hispanic ethnicity | 1.74 (1.06–2.92) | 0.031 |
| ADH | 2.69 (1.62–4.56) | <0.001 | |
| Interference with mammogram/breast examination | Private health insurance | 1.70 (1.10–2.66) | 0.019 |
| Risk of needing additional operation(s) | Hispanic ethnicity | 2.39 (1.27–4.85) | 0.010 |
| Risk of capsular contracture | Hispanic ethnicity | 2.11 (1.19–3.96) | 0.015 |
*Respondents had the option to list their insurance type as private coverage, Medicare/Medicaid, or other/not applicable. “Other insurance type” reflects a response of “other/not applicable.”